Analyze Diet
Molecular immunology2022; 151; 231-241; doi: 10.1016/j.molimm.2022.09.011

The major role of junctional diversity in the horse antibody repertoire.

Abstract: The antibody repertoire (Rep-seq) sequencing revolutionized the diversity of antigen B cell receptor studies, allowing deep and quantitative analysis to decipher the role of adaptive immunity in health and disease. Particularly, horse (Equus caballus) polyclonal antibodies have been produced and used since the century XIX to treat and prophylaxis diphtheria, tuberculosis, tetanus, pneumonia, and, more recently, COVID-19. However, our knowledge about the horse B cell receptors repertories is minimal. We present a deep horse antibody heavy chain repertoire (IGH) characterization of non-infected horses using NGS (Next generation sequencing). This study obtained a mean of 248,169 unique IgM clones and 66,141 unique IgG clones from four domestic adult horses. Rarefaction analysis showed sequence coverage was between 52 % and 82 % in IgM and IgG isotypes. We observed that besides horses antibody can use all functional IGHV genes, around 80 % of their antibodies use only three IGHV gene segments, and around 55 % use only one IGHJ gene segment. This limited VJ diversity seems to be compensated by the junctional diversity of these antibodies. We observed that the junctional diversity in horse antibodies is widespread, present in more than 90 % of horse antibodies. Besides this, the length of this region seems to be higher in horse antibodies than in other species. N1 and N2 nucleotides addition range from 0 to 111 nucleotides. In addition, around 45 % of the antibody clones have more than ten nucleotides in both the N1 and N2 junction regions. This diversity mechanism may be one of the most important in providing variability to the equine antibody repertoire. This study provides new insights regarding horse antibody composition, diversity generation, and particularities compared to other species, such as the frequency and length of N nucleotide addition. This study also points out the urgent need to better characterize TdT in horses and other species to better understand antibody repertoire characteristics.
Publication Date: 2022-09-27 PubMed ID: 36179605DOI: 10.1016/j.molimm.2022.09.011Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Journal Article
  • Research Support
  • Non-U.S. Gov't
  • Research Support
  • N.I.H.
  • Extramural

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

This research provides a detailed examination of the antibody diversity in horses, particularly emphasizing the importance of junctional diversity. Utilizing next generation sequencing, the study found that while horses can use all functional IGHV genes, the majority of their antibodies use a limited selection, and the diversity is significantly enriched by junctional diversity.

Study Design and Findings

The study began by conducting a profound investigation into the antigen B cell receptor diversity of non-infected adult horses. This was achieved by applying Next Generation Sequencing (NGS), a powerful technology providing deep and quantitative analysis that allows researchers to explore adaptive immunity in health and disease:

  • The NGS study yielded a mean of 248,169 unique IgM clones and 66,141 unique IgG clones in the four horses that were studied.
  • Coverage analysis indicated that the sequence coverage was between 52% and 82% for IgM and IgG isotypes, indicating that the sequencing effort was adequate to capture a large proportion of the repertoire.
  • The study observed that while horses’ antibodies can use all functional IGHV genes, the majority of their antibodies – about 80% – use only three IGHV gene segments.
  • A narrowing of diversity was also observed in the fact that around 55% of their antibodies use only one IGHJ gene segment.

Junctional Diversity and its Role

The limited diversity as observed in the above findings is significantly compensated by junctional diversity in horse antibodies:

  • Junctional diversity was found in over 90% of horse antibodies, showcasing its ubiquity and importance in the equine antibody repertoire.
  • The study also highlighted that the junctional region length in horse antibodies appears to be longer than in other species, suggesting a stronger role for junctional diversity in providing variability in horses.
  • The range of N1 and N2 nucleotides addition was observed to vary between 0 to 111 nucleotides, thereby reinforcing this hypothesis.
  • Significantly, around 45% of the antibody clones were found to have more than ten nucleotides in both the N1 and N2 junction regions.

Based on these findings, the study puts forward that junctional diversity may be one of the most crucial mechanisms providing variability to the equine antibody repertoire.

Conclusions and Future Recommendations

The study offers fresh insights on horse antibody composition, how its diversity is generated, and its unique characteristics compared to other species. This includes details about the frequency and length of N nucleotide addition. The research also signals the need for more studies to better characterize TdT in horses and other species for gaining further understanding of the antibody repertoire characteristics.

Cite This Article

APA
Navas C, Manso T, Martins F, Minto L, Moreira R, Minozzo J, Antunes B, Vale A, McDaniel JR, Ippolito GC, Felicori LF. (2022). The major role of junctional diversity in the horse antibody repertoire. Mol Immunol, 151, 231-241. https://doi.org/10.1016/j.molimm.2022.09.011

Publication

ISSN: 1872-9142
NlmUniqueID: 7905289
Country: England
Language: English
Volume: 151
Pages: 231-241
PII: S0161-5890(22)00433-3

Researcher Affiliations

Navas, Carlena
  • Laboratory of Synthetic Biology and Biomimetics, Departamento de Bioquímica e Imunologia, Instituto de Ciências Biológicas - ICB, Universidade Federal de Minas Gerais, Belo Horizonte, Brazil; University of Carabobo, Faculty of Health Sciences, School of Biomedical and Technological Sciences Department of Morphological and Forensic Sciences, Valencia, Venezuela.
Manso, Taciana
  • Laboratory of Synthetic Biology and Biomimetics, Departamento de Bioquímica e Imunologia, Instituto de Ciências Biológicas - ICB, Universidade Federal de Minas Gerais, Belo Horizonte, Brazil; The International Immunogenetics Information System, IMGT Institut de Génétique Humaine, IGH - CNRS, Montpellier, France.
Martins, Fabio
  • Laboratory of Synthetic Biology and Biomimetics, Departamento de Bioquímica e Imunologia, Instituto de Ciências Biológicas - ICB, Universidade Federal de Minas Gerais, Belo Horizonte, Brazil.
Minto, Lucas
  • Laboratory of Synthetic Biology and Biomimetics, Departamento de Bioquímica e Imunologia, Instituto de Ciências Biológicas - ICB, Universidade Federal de Minas Gerais, Belo Horizonte, Brazil.
Moreira, Rennan
  • Multi-users Laboratories Center, Instituto de Ciências Biológicas - ICB, Universidade Federal de Minas Gerais, Belo Horizonte, Brazil.
Minozzo, João
  • Production and Research Centre of Immunobiological Products, Department of Health of the State of Paraná, Piraquara 83302-200, Brazil.
Antunes, Bruno
  • Production and Research Centre of Immunobiological Products, Department of Health of the State of Paraná, Piraquara 83302-200, Brazil.
Vale, André
  • Program in Immunobiology, Carlos Chagas Filho Institute of Biophysics, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil.
McDaniel, Jonathan R
  • Department of Molecular Biosciences, The University of Texas at Austin, 100 E. 24th Street, Stop A5000, Austin, TX 78712, USA.
Ippolito, Gregory C
  • Department of Molecular Biosciences, The University of Texas at Austin, 100 E. 24th Street, Stop A5000, Austin, TX 78712, USA.
Felicori, Liza F
  • Laboratory of Synthetic Biology and Biomimetics, Departamento de Bioquímica e Imunologia, Instituto de Ciências Biológicas - ICB, Universidade Federal de Minas Gerais, Belo Horizonte, Brazil. Electronic address: liza@icb.ufmg.br.

MeSH Terms

  • Animals
  • Antibody Diversity
  • COVID-19
  • Horses
  • Immunoglobulin G / genetics
  • Immunoglobulin M / genetics
  • Nucleotides
  • Receptors, Antigen, B-Cell / genetics

Grant Funding

  • R01 AI143552 / NIAID NIH HHS

Conflict of Interest Statement

Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Citations

This article has been cited 0 times.